Found: 9
Select item for more details and to access through your institution.
Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Leukocytes mediate retinal vascular remodeling during development and vaso-obliteration in disease.
- Published in:
- Nature Medicine, 2003, v. 9, n. 6, p. 781, doi. 10.1038/nm877
- By:
- Publication type:
- Article
Feasibility demonstration of a device for vitreous liquid biopsy incidental to intravitreal injection.
- Published in:
- PLoS ONE, 2024, v. 19, n. 1, p. 1, doi. 10.1371/journal.pone.0294526
- By:
- Publication type:
- Article
Reply to “FasL, leukocytes and vascular modeling”.
- Published in:
- Nature Medicine, 2004, v. 10, n. 1, p. 13, doi. 10.1038/nm0104-13
- By:
- Publication type:
- Article
Anti-VEGF Aptamer (Pegaptanib) Therapy for Ocular Vascular Diseases.
- Published in:
- Annals of the New York Academy of Sciences, 2006, v. 1082, n. 1, p. 151, doi. 10.1196/annals.1348.062
- By:
- Publication type:
- Article
A central role for inflammation in the pathogenesis of diabetic retinopathy.
- Published in:
- FASEB Journal, 2004, v. 18, n. 12, p. 1450, doi. 10.1096/fj.03-1476fje
- By:
- Publication type:
- Article
Suppression of Fas‐FasL‐induced endothelial cell apoptosis prevents diabetic blood‐retinal barrier breakdown in a model of streptozotocin‐induced diabetes.
- Published in:
- FASEB Journal, 2003, v. 17, n. 1, p. 76, doi. 10.1096/fj.02-0157fje
- By:
- Publication type:
- Article
Characterization of retinal leukostasis and hemodynamics in insulin resistance and diabetes: role of oxidants and protein kinase-C activation.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Regulation of vascular endothelial growth factor expression by insulin-like growth factor I.
- Published in:
- 1997
- By:
- Publication type:
- journal article